| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00011-018-1193-0 |
| P698 | PubMed publication ID | 30317465 |
| P50 | author | Tadahiro Hashita | Q87624326 |
| Satoshi Kondo | Q89476055 | ||
| Tamihide Matsunaga | Q92261536 | ||
| Takahiro Iwao | Q92525222 | ||
| P2093 | author name string | Shota Mizuno | |
| P2860 | cites work | Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 |
| The influence of indomethacin on the metabolism and cytokine secretion of human aneurysmal aorta | Q28368179 | ||
| OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability | Q30651186 | ||
| Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells | Q33223955 | ||
| Deoxycholic acid induces the overexpression of intestinal mucin, MUC2, via NF-kB signaling pathway in human esophageal adenocarcinoma cells | Q33384875 | ||
| Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2, and fever. | Q34102619 | ||
| Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury | Q34124785 | ||
| Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer? | Q34386496 | ||
| Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo | Q34392953 | ||
| Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds | Q35554963 | ||
| Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice | Q35813196 | ||
| Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial | Q36040552 | ||
| Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells. | Q36078060 | ||
| Mucosal barrier in ulcerative colitis and Crohn's disease | Q36877117 | ||
| Prophylactic effect of monosodium glutamate on NSAID-induced enteropathy in rats | Q38124127 | ||
| Differentiation of human induced pluripotent stem cells into functional enterocyte-like cells using a simple method | Q39131049 | ||
| Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer | Q39563275 | ||
| Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors. | Q39753880 | ||
| TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation. | Q40467064 | ||
| Interleukin-1beta induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, and PI3K in human airway epithelial cells | Q40683375 | ||
| Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. | Q40873306 | ||
| Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model | Q41361724 | ||
| Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats | Q42152120 | ||
| Indomethacin can downregulate the levels of inflammatory mediators in the hippocampus of rats submitted to pilocarpine-induced status epilepticus | Q42938818 | ||
| Protective effect of rebamipide on indomethacin-induced intestinal damage in rats | Q43784939 | ||
| Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study | Q43871043 | ||
| Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility | Q44855808 | ||
| Tumor necrosis factor-alpha stimulates mucin secretion and cyclic GMP production by guinea pig tracheal epithelial cells in vitro | Q44870924 | ||
| Cinacalcet, a calcimimetic, prevents nonsteroidal antiinflammatory drug-induced small intestinal damage in rats | Q44943681 | ||
| Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model | Q44981253 | ||
| Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy | Q46108964 | ||
| A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy | Q46485023 | ||
| Rebamipide upregulates mucin secretion of intestinal goblet cells via Akt phosphorylation. | Q47688891 | ||
| Interaction of indomethacin with cytokine production in whole blood. Potential mechanism for a brain-protective effect | Q49145776 | ||
| Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits | Q50254467 | ||
| Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats. | Q54601716 | ||
| Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis | Q73927834 | ||
| Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study | Q77348864 | ||
| Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats | Q77348911 | ||
| Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy) | Q79745265 | ||
| Cyclic AMP Signaling Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Intestinal Epithelial Cells | Q90696095 | ||
| P433 | issue | 11-12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 975-984 | |
| P577 | publication date | 2018-10-13 | |
| P1433 | published in | Inflammation Research | Q1819367 |
| P1476 | title | Using human iPS cell-derived enterocytes as novel in vitro model for the evaluation of human intestinal mucosal damage | |
| P478 | volume | 67 |
| Q80019346 | Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events | cites work | P2860 |
Search more.